Find Academic Supervisors

Marjo Yliperttula is a Professor at the Department of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki. She serves as a supervisor in the Doctoral Programmes in Biomedicine, Drug Research, and Materials Research and Nanosciences, with expertise in biomaterials and pharmaceutical technology. Her research focuses on nanofibrillated cellulose (NFC) hydrogels for wound healing and drug delivery, extracellular vesicle (EV) engineering for therapeutic applications, and freeze-drying technologies for biomaterial preservation. Key contributions include NFC-based wound dressings that enhance platelet-rich plasma release (2024), Raman spectroscopy methods for monitoring freeze-drying-induced mutarotation (2024), and tandem chromatography techniques for high-purity EV isolation (2023). Her work bridges pharmaceutical sciences with regenerative medicine, emphasizing translational applications in chronic wound treatment and targeted drug delivery. Recent publications (2022-2025) reveal three dominant trends: (1) Optimization of NFC hydrogels for controlled drug release and tissue regeneration, (2) Advanced characterization of EV phenotypes under hypoxic conditions for improved therapeutic efficacy, and (3) Development of analytical methods (Raman spectroscopy, chromatography) to address manufacturing challenges in biopharmaceuticals. These themes reflect her group's commitment to solving critical problems in biomaterial stability, EV-based delivery, and precision wound care. Professor Yliperttula has supervised 10 doctoral theses, including recent work on NFC for skin substitutes (Elle Koivunotko), freeze-drying of hydrogels (Arto Merivaara), and mesenchymal stromal cells for wound healing (Jasmi Snirvi). She currently leads the Academy of Finland-funded GeneCellNa project (2024-2026) on gene/cell/nanotherapy for chronic diseases and a Finnish Red Cross project (2023-2024) on NFC for blood products, with cumulative project funding spanning 18 initiatives since 2005. She heads the Biopharmaceuticals Group within the Drug Research Program, fostering collaborations across pharmaceutical biosciences, materials science, and clinical medicine to advance next-generation therapeutic platforms.

• Biomaterials
• Nanomedicine
• Drug Delivery
• +5 more

Leila Deravi is an Associate Professor of Chemistry and Chemical Biology at Northeastern University's College of Science, affiliated with the Barnett Institute of Chemical and Biological Analysis and the Institute for Chemical Imaging of Living Systems. Her research focuses on biomaterials design, particularly protein-based systems inspired by biological mechanisms in cephalopods and extracellular matrices. She leads the Biomaterials Design Group, which explores applications ranging from tissue engineering to wearable electronics. Her work integrates bioanalytical chemistry, materials science, and design, with projects including cephalopod pigment studies for sunscreen development and bionic material fabrication using additive manufacturing. She has secured significant grants, including an NSF award and U.S. Army funding, and co-founded Seaspire Skincare, leveraging marine biotechnology. Key Research Themes: Bio-inspired materials, cephalopod pigmentation, biomedical textiles, and sustainable cosmetics Notable Collaborations: Cross-disciplinary projects with engineering, biology, and entrepreneurship Innovation: Development of UV-sensing devices and eco-friendly skincare products Deravi's educational contributions include innovative chemistry courses where students design cosmetics, bridging theory and practical application. Her lab's work frequently appears in media discussions on skincare trends and environmental chemistry advancements.

• Biomaterials Science
• Biotechnology
• Bioanalytical Chemistry
• +5 more

Mathangi Gopalakrishnan, PhD, MPharm, is an Associate Professor in the Department of Practice, Science, and Health Outcomes Research at the University of Maryland School of Pharmacy. She is actively engaged in research, mentoring, and academic scholarship, with a focus on quantitative clinical pharmacology and data-driven therapeutic optimization. Education: PhD, Statistics, University of Maryland, Baltimore County MS, Statistics, University of Maryland, Baltimore County MPharm, Birla Institute of Technology & Science, Pilani, Rajasthan, India BPharmacy (Honors), Birla Institute of Technology & Science, Pilani, Rajasthan, India Her research interests center on pharmacometrics, precision therapeutics, predictive analytics, real-world data, and drug development . She integrates principles of clinical pharmacology, advanced frequentist and Bayesian statistical methods, and artificial intelligence/machine learning to enhance patient outcomes, particularly among vulnerable populations. Her lab's work includes designing prospective clinical pharmacokinetic trials for anti-epileptics and antimicrobials in patients on continuous renal replacement therapy, leveraging real-world data from electronic health records to optimize dosing in neonatal opioid withdrawal syndrome and pediatric anticoagulation, and developing models for disease progression in conditions like schizophrenia and binge-eating disorders. The trends in her recent publications reflect a consistent focus on model-informed precision dosing, real-world evidence generation, pharmacokinetic-pharmacodynamic (PK/PD) modeling in special populations, and methodological innovation in clinical trial design . Her work spans diverse therapeutic areas including critical care, neonatology, psychiatry, and maternal health, demonstrating a broad impact of quantitative pharmacology. Dr. Gopalakrishnan is accepting applications for postdoctoral positions in pharmacometrics at the Center for Translational Medicine, indicating active research funding and team leadership. Her collaborations extend to academic medical institutions nationwide, underscoring her role in multi-center research initiatives. She is involved in collaborative research with academic medical institutions across the country and has presented her work at major conferences including the Joint Statistical Meetings (JSM) and the American Conference on Pharmacometrics (ACoP).

• Pharmacometrics
• Precision Therapeutics
• Predictive Analytics
• +9 more

Dr. Suzi Mansu is a Senior Lecturer in the Department of Health and Biomedical Sciences at RMIT University, located at the Bundoora West campus. Her research focuses on Complementary and Alternative Medicine and Clinical Sciences, with a particular emphasis on acupuncture safety, herbal medicine efficacy, and systematic reviews in dermatology and infectious diseases. She has contributed to studies on birth-related trauma support, acne vulgaris treatments, and respiratory disorder management through traditional Chinese medicine frameworks. Education : No formal educational details provided in the text. Her research interests span acupuncture safety assessments, herbal formulations for skin and infectious conditions, and integrating digital tools into medical education. Recent work includes a 2025 scoping review on midwifery practices for birth-related trauma and a 2018 meta-analysis on acupuncture for acne vulgaris. Dr. Mansu is open to supervising Masters and PhD students in relevant fields. She has collaborated on interdisciplinary projects, including the SOPE educational model for online herbal medicine training.

• Complementary and Alternative Medicine
• Clinical Sciences
• Acupuncture
• +3 more

Professor Richard Blackburn is a Professor of Sustainable Materials at the University of Leeds, School of Design. His research focuses on applying sustainability principles to materials science, textile coloration, and cosmetics. He leads the Sustainable Materials Research Group and co-founded Keracol Limited, a spin-out company developing natural cosmetic ingredients from plant extracts. His work includes innovations in dyeing technologies, reducing microfibre pollution, and sustainable textile processing. Education: BSc (Hons) and PhD in Colour Chemistry from the University of Leeds Professional Memberships: Fellow of the Royal Society of Arts, Royal Society of Chemistry, and Society of Dyers and Colourists. Key research interests span sustainable textile practices, natural dye extraction, polymer chemistry, and green chemistry applications. He has pioneered methods for extracting actives from food waste for cosmetics and developed fluorine-free repellent coatings for textiles. Awards: Silver Medal (Society of Dyers and Colourists, 2016) Fellowship (Society of Dyers and Colourists, 2017) Centenary Medal (2018 & 2019) Freedom of The City of London (2013) Advising & Grants: Leads multidisciplinary projects on textile sustainability, including FoodWasteNet and the Business of Fashion, Textiles and Technology partnership. His work bridges academia and industry through spin-offs like Keracol and RITE Group, focused on minimizing environmental impact. Labs & Teams: Head of the Sustainable Materials Research Group and collaborator with global industry partners to advance sustainable materials innovation.

• Sustainability
• Textile Chemistry
• Cosmetics
• +7 more

Jennifer Fiegel serves as Professor and Chair of the Department of Chemical and Biomedical Engineering at the University of Missouri, leveraging over two decades of interdisciplinary expertise in aerosol science and educational innovation to advance therapeutic delivery systems and engineering pedagogy. Her academic foundation includes a BS from the University of Massachusetts at Amherst and a PhD from Johns Hopkins University. Dr. Fiegel's research program operates at the convergence of biomedical engineering and education science . Her drug delivery work pioneers inhalable/sprayable therapeutics targeting respiratory and skin infections through nanoparticle engineering and biofilm eradication strategies, while her education research develops metacognitive frameworks for ethical decision-making and faculty development. Key innovations include thermoreversible hydrogels for wound treatment and scaffolded 52-week initiatives transforming engineering culture. Recent publications reveal accelerating integration between her dual research domains, with nanoparticle delivery systems increasingly addressing complex biological barriers (mucus, biofilms) while educational frameworks evolve toward longitudinal cultural transformation in engineering education through choose-your-own-path simulations and TA empowerment programs. Dr. Fiegel directs collaborative research teams spanning engineering and health sciences, mentoring students through hands-on projects in aerosol characterization and educational intervention design. Her leadership includes developing comprehensive faculty development journeys focused on inclusive climate initiatives and evidence-based teaching practices. Her laboratories maintain dual focus: the Aerosol Drug Delivery Lab developing advanced formulations for pulmonary and topical applications, and the Engineering Education Innovation Lab creating metacognitive training modules and ethical decision-making simulations for engineering curricula.

• Drug Delivery
• Aerosol Science
• Engineering Education
• +3 more

J. Andrew Orr-Skirvin is a Clinical Professor in the Department of Pharmacy and Health Systems Sciences at Northeastern University's Bouvé College of Health Sciences. He serves as Director of the Pharmaceutical Industry Fellowship Program. His expertise spans oncology pharmacy practice, with a focus on supportive care for cancer patients, including pain management, nausea/vomiting control, neutropenic fever, and growth factor support. Education: PharmD, University of Texas at Austin BS in Pharmacy, Oregon State University His research emphasizes improving patient outcomes through evidence-based pharmacotherapy in oncology settings. Key publications explore drug interactions in elderly cancer patients, antineoplastic agent pharmacokinetics, and pain management protocols. He holds Board Certification in Oncology Pharmacy (BCOP). Publications highlight advancements in chemotherapy safety, pharmacokinetic optimization, and supportive care strategies. His work bridges clinical practice and academic rigor, addressing real-world challenges in oncology pharmacotherapy. Community Service: Engages in direct clinical service to cancer patients through practice-based initiatives.

• Oncology Pharmacy
• Cancer Supportive Care
• Pharmacotherapy
• +3 more

Rohan Shah is a Lecturer at Swinburne University of Technology's Department of Chemistry and Biotechnology, School of Science, Computing and Emerging Technologies. He holds a PhD from Swinburne, supported by the Victoria-India Doctoral Scholarship, and was awarded the Sparrho Early Career Researcher Prize for lipid nanoparticle work. His research focuses on nanomedicine, antimicrobial peptides, and sustainable biotechnology solutions for global health challenges. He has held academic roles at Swinburne and RMIT, including Lecturer and Academic Tutor, and is a registered pharmacist and Chartered Member of the Royal Australian Chemical Institute (RACI). Dr. Shah's research explores targeted drug delivery systems, systems biology, and metabolomics applications in food and environmental science. He has secured significant grants (e.g., $1.2M+ in external funding) and collaborates globally. His editorial roles include Frontiers in Sustainable Food Systems, Metabolites, and Food Science and Nutrition Cases. He has authored over 100 publications, with recent work addressing PFAS toxicity in wildlife, food additive health impacts, and nanoformulated drug delivery. Professional activities include serving as Treasurer of the RACI's Early Career Chemists Group and committee roles in the Young Chemists Group. His work spans 15+ years of grants, 99+ publications, and supervision of four HDR students. He advocates for food additive reformulation, sustainable technologies, and improved drug delivery systems.

• Nanomedicine
• Targeted Drug Delivery Systems
• Antimicrobial Peptides
• +7 more

Dr. Eng. Katarzyna Bialik-Wąs is a Research and Teaching Assistant at the Department of Polymer Chemistry and Technology, Faculty of Chemical Engineering and Technology, Tadeusz Kościuszko Cracow University of Technology. She earned her MSc in Light Organic Technology (2009) and PhD in Chemical Technology (2015) from the same institution, followed by postgraduate studies in Biomaterials at AGH University of Science and Technology (2016). Specializes in hydrogel synthesis, nanotechnology, and biomedical applications Focuses on wound-healing materials, drug delivery systems, and biocompatibility testing Research Trends: Her 15 most recent publications (2017-2024) highlight expertise in: designing hydrogel matrices , nanoparticle-polymer composites , and controlled drug release mechanisms . Key topics include chitosan/silver/gold nanoparticle integration , natural extract applications (Aloe vera, Echinacea purpurea), and stimuli-responsive nanocarriers . Contact: Email: katarzyna.bialik-was@pk.edu.pl Phone: +12 628 27 98

• Polymer Chemistry
• Biomaterials
• Hydrogels
• +5 more

Dr. Salwa Karboune is a Professor at McGill University, where she serves as Dean of the Faculty of Agricultural and Environmental Sciences and Associate Vice-Principal at the Macdonald Campus. She is also the Scientific Director of the Consortium for Research, Innovation and Transformation of Agrifood. Based at the Macdonald Campus in Montreal, she maintains research offices in the Raymond Building and Food Science facilities in the Macdonald-Stewart Building. Her research focuses on innovative green bioprocesses for developing novel food ingredients and nutraceuticals, with particular emphasis on carbohydrate-active enzymes for synthesizing tailored prebiotic oligosaccharides and functional polysaccharides. She investigates enzymatic cross-linking of proteins with polysaccharides and develops enzyme technology solutions for converting biomass into valuable bioactive products. Her work bridges fundamental enzyme science with practical food applications, addressing challenges in food security and sustainability. Analysis of her publication record reveals consistent research themes centered around enzyme technology (particularly levansucrases), prebiotic synthesis, functional food development, and valorization of agricultural by-products. Her recent work shows increased focus on nanoencapsulation techniques, lactic acid bacteria applications for food preservation, and investigation of plant-based protein peptides with health-promoting properties. The interdisciplinary nature of her research integrates food science, biochemistry, microbiology, and nanotechnology to address contemporary food system challenges. Dr. Karboune's leadership extends beyond her research laboratory, as evidenced by her dual administrative roles overseeing academic programs and research initiatives at McGill's Macdonald Campus. Her position as Scientific Director of the Consortium for Research, Innovation and Transformation of Agrifood demonstrates her commitment to translating scientific discoveries into practical food system innovations. While specific details about her laboratory infrastructure aren't provided in the source material, her extensive publication record suggests a well-equipped research facility supporting multiple graduate students and collaborators working on enzyme technology and food bioprocessing projects.

• Food Science
• Enzyme Technology
• Bioprocessing
• +6 more

Anne Filppula is a Senior University Lecturer at the Faculty of Science and Engineering , Department of Pharmacy Solutions for Health at Åbo Akademi University. She holds a PhD and a Docent title in translational drug research from the University of Helsinki. Her research focuses on drug metabolism, pharmacogenetics, and innovative drug delivery systems, particularly involving CYP enzymes and drug-drug interactions. Key research areas include Clopidogrel pharmacokinetics , metabolism of CYP2C8 substrates , and hydrogel-based therapies . She has contributed to projects like the Nordic Pharmaceutical Translation and Innovation (2024–2028) and Nordic POP (2018–2025), emphasizing patient-oriented pharmaceutical solutions. Her recent publications highlight advancements in extrusion-based drug formulation , mitochondrial transplantation , and hydrogel-responsive biomaterials . She actively participates in academic activities such as the 1st Helsinki Organ-on-a-chip meeting and serves on examination boards for doctoral defenses. Education: PhD in Pharmacy, Docent in Translational Drug Research (University of Helsinki) Projects: Co-PI in Nordic-funded pharmaceutical innovation initiatives Grants: NordForsk-supported research programs Labs/Teams: Involved in Pharmacy Solutions for Health research groups

• Pharmacology
• Pharmaceutical Science
• Drug Metabolism
• +3 more

Dr. Jennifer Goldstein is a Professor of Educational Leadership in the College of Education at California State University, Fullerton (CSUF). As Director of the LEAD program, she focuses on improving educational quality for underserved communities, particularly through university-district partnerships and dismantling antisemitism in education. Her research emphasizes teacher leadership, policy analysis, and equity-driven frameworks. Her publications include the 2024 book Radical University-District Partnerships and articles exploring partnerships for leadership preparation (2025), urban education dynamics (2023), and teacher evaluation systems. She actively engages with educational communities through podcasts like AUHSD Future Talks, discussing leadership preparation, whole-child education, and innovative program models such as LEAD. Her work spans diverse topics from systemic accountability frameworks (2007–2009) to wellness and interdisciplinary approaches in education. Despite the breadth of her research, a core theme is bridging institutional gaps to foster equitable educational opportunities. She holds no explicitly stated awards but is recognized for her contributions to teacher leadership and partnership models. Dr. Goldstein advises the LEAD program, though no specific advisees are listed. Her affiliations include the Department of Educational Leadership at CSUF and collaborations with local school districts. She advocates for community-driven solutions to educational challenges through both academic and applied initiatives.

• Educational Leadership
• Policy Analysis
• Teacher Leadership
• +3 more

Milton A. Fuentes is Professor of Psychology at Montclair State University and Interim Chairperson of Social Work and Child Advocacy. His research examines child maltreatment prevention through culturally responsive frameworks and advances equity in psychological science and education. Education: Psy.D. Clinical Psychology, Rutgers University Psy.M. Rutgers University M.A. Psychology, Montclair State University B.A. Saint Peters College Research focuses on multicultural psychology and child/family wellbeing: Child maltreatment prevention across cultural communities Latinx psychology and mental health disparities Diversity science and cultural humility Equity-focused pedagogy in psychology education Recent publications include the book series 'Preventing Child Maltreatment across Cultures' examining child protection through feminist, multicultural, and social justice frameworks. This work has been recognized by leading experts in child welfare and cultural psychology. Honors include the 2023 Society for Teaching of Psychology Promoting Diversity, Equity, and Inclusion Award and Fellow status in the American Psychological Association. Serves as consultant to academic institutions and agencies on DEI strategic planning.

• Latinx Psychology
• Child and Family Psychology
• Diversity Science
• +2 more

James Flory is an Associate Professor of Population Health Sciences at Weill Cornell Medical College , Cornell University. With an MD and MSCE from the University of Pennsylvania (2009) and a BA from Columbia University (2002), he specializes in pharmacoepidemiology and clinical research related to diabetes management, drug safety, and healthcare policy. Education: M.D., University of Pennsylvania School of Medicine, 2009 M.S.C.E., University of Pennsylvania School of Medicine, 2009 B.A., Columbia University, 2002 His research focuses on the intersection of diabetes pharmacology , cardiovascular risk , and health services research . He has contributed extensively to understanding drug safety (e.g., sulfonylureas, SGLT2 inhibitors, TRK inhibitors), medication adherence , and clinical decision-making in diabetes and oncology settings. His methodological work includes instrumental variable analysis , pragmatic trial design , and real-world data validation . James Flory's recent publications examine temperature-related diabetes complications , AI in clinical decision support , and policy impacts on medication utilization . His work combines epidemiological methods with health informatics to address critical questions in diabetic care , drug safety surveillance , and health equity .

• Pharmacoepidemiology
• Diabetes Management
• Clinical Trials
• +3 more

Rico Del Sesto is a Professor of Chemistry at Utah Tech University, where he has been a faculty member since 2012. He previously served as Department Chair of Physical Sciences (2017-2021) and Director of the Research Office (2014-2022). Currently, he directs the Center for Climate Resilience and Sustainability. His career includes significant research positions at Los Alamos National Laboratory (2004-2012) and a National Research Council Postdoctoral Fellowship at the US Air Force Academy (2002-2004). Dr. Del Sesto received his education from prestigious institutions: Ph.D. in Organic Chemistry, University of Utah, 2002 B.A. in Chemistry, Colby College, Waterville, ME, 1997 His research interests span multiple interdisciplinary fields with a focus on materials chemistry. Dr. Del Sesto leads the Functional Materials Laboratory, which develops new materials with functional properties including optical, magnetic, electronic, and mechanical characteristics through strategic molecular design. His work bridges organic chemistry with applications in materials science, biology, inorganic chemistry, and physics. Current research projects address critical challenges in materials science, energy, national security, and climate resilience through collaborations with the Departments of Energy, Defense, Homeland Security, and the Intelligence Community. Analysis of his recent publications reveals a consistent research trajectory focused on ionic liquids and their diverse applications. His work spans from fundamental chemical properties to practical implementations in biomedical, security, and energy contexts. A notable trend is the evolution from basic ionic liquid chemistry toward increasingly sophisticated applications in drug delivery, antimicrobial technologies, and advanced materials for energy storage. Dr. Del Sesto has received significant recognition for his work, including: National Academies of Science Postdoctoral Fellowship Multiple patents with practical applications Front cover features for several publications Highlighting in Nature and Scientific American for groundbreaking research 'top 25' most cited in Journal of Organometallic Chemistry As an educator and mentor, Dr. Del Sesto has secured over $8 million in research funding as Principal Investigator for more than 15 programs from DOE, DOD, and DHS. He teaches a comprehensive range of courses from introductory organic chemistry to advanced materials chemistry. Drawing from his own experience as a first-generation, underrepresented undergraduate student, he actively encourages diversity in STEM research participation. His educational philosophy emphasizes connecting chemistry to real-world applications and the broader context of students' lives. Dr. Del Sesto contributes to scientific community engagement through regional Science Café events and his leadership in the Center for Climate Resilience and Sustainability, demonstrating commitment to both fundamental research and practical societal impact.

• Organic Chemistry
• Materials Science
• Ionic Liquids
• +7 more